معرفی
Dr. Olaf Perdijk is an Assistant Professor in the Department of Pharmacology at the Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University. His research focuses on understanding the intricate mechanisms by which host-microbe interactions in the gut modulate systemic and local immune responses and disease susceptibility. He aims to harness the therapeutic potential of microbes and metabolites through innovative approaches.
Dr. Perdijk earned his PhD from Wageningen University in 2018, where he investigated novel early-life ingredients derived from raw cow's milk and their potential to modulate immune responses in neonates. Following his doctoral studies, he joined the Mucosal Immunology Research Group at Monash University, Australia, focusing on gut microbe-immune system communication in allergic diseases such as atopic dermatitis and allergic asthma.
His research spans two primary arms:
- Preventing childhood asthma through early-life microbiome interventions and understanding the metabolic requirements of developing airway epithelium
- Exploring gut-brain axis interactions, particularly how ketogenic diets modulate neuronal excitability and epilepsy susceptibility, and how postbiotics regulate systemic metabolic and immune health
His recent publications reveal a strong focus on microbial metabolites and their regulatory roles in immunity. Key themes include how short-chain fatty acids influence skin barrier integrity, microbial metabolism of tyrosine in protecting against airway inflammation, and how antibiotic-induced dysbiosis disrupts metabolite production leading to exacerbated allergic responses. His 2024 review in Physiological Reviews establishes the microbiome as an integral player in respiratory immunity, while his work on neuroimmunology bridges immunology and neuroscience in understanding lung function.
As an educator, Dr. Perdijk teaches courses including Pharma and Nutrition (CPS-333), Immunopharmacology (FA-MA215), Advanced Pharmacology (DI-411-13), and tutorials on chronic inflammatory conditions (FA-BA303). His teaching directly reflects his research expertise in mucosal immunology, host-microbiome interactions, and immunopharmacology.
Dr. Perdijk's work has garnered significant attention in the scientific community, with multiple publications featured in high-impact journals and picked up by numerous news outlets. His research on the microbiome's role in respiratory immunity and the gut-brain axis represents cutting-edge interdisciplinary science with potential therapeutic applications.
